.
This commit is contained in:
@@ -1,320 +0,0 @@
|
||||
---
|
||||
title: "Spinocerbellar Ataxia"
|
||||
docid: "df64565a-5c8c-4387-879b-b341b655e478"
|
||||
breadcrumbs:
|
||||
- "Brain"
|
||||
- "Diagnosis"
|
||||
- "Pathology-Based Diagnoses"
|
||||
- "Acquired Toxic/Metabolic/Degenerative Disorders"
|
||||
- "Dementias and Degenerative Disorders"
|
||||
- "Spinocerbellar Ataxia"
|
||||
---
|
||||
# KEY FACTS
|
||||
|
||||
- ## Terminology
|
||||
|
||||
|
||||
- Spinocerebellar ataxia (SCA)
|
||||
- ## Imaging
|
||||
|
||||
|
||||
- Cerebellum atrophy always, brainstem often
|
||||
- Supratentorial atrophy variably in volumetric analysis
|
||||
- Cerebellum & pontine tegmentum (dorsal pons) atrophy in SCA1, SCA3 [Machado-Joseph disease (MJD)], DRPLA
|
||||
- Cerebellum & pontine base (ventral pons) atrophy in SCA2
|
||||
- Pontine base:tegmentum distance ratio (BT-ratio) useful
|
||||
- Cerebellum atrophy purely/predominantly in SCA5, SCA6, SCA11, SCA26, SCA30, SCA31, SCA37
|
||||
- Superior cerebellar peduncle atrophy in MJD, SCA6, SCA8, DRPLA; severe cerebral atrophy in juvenile-onset DRPLA
|
||||
- Medulla & upper cervical cord atrophy in SCA3 (MJD); relative lack of cord involvement in SCA6
|
||||
- Hot cross bun sign in pons in SCA2 & rarely MJD
|
||||
- Anteroposteriorly oriented pontine midline linear T2-hyperintensity (PMH) in SCA1, SCA2, SCA3 (MJD), DRPLA
|
||||
- Bilateral bright middle cerebellar peduncle (MCP) sign rarely in SCA2, SCA3 (MJD), SCA6, DRPLA
|
||||
- Cerebral white matter (WM), brainstem, & thalamic hyperintensities in adult-onset DRPLA
|
||||
- Cerebral WM signal abnormalities usually absent in juvenile-onset DRPLA
|
||||
- Periventricular WM changes may be seen in very late stage
|
||||
- ## Top Differential Diagnoses
|
||||
|
||||
|
||||
- Multiple system atrophy-cerebellar (MSA-C)
|
||||
- Friedrich ataxia
|
||||
- Ataxia with oculomotor apraxia types 1 & 2
|
||||
- Ataxia telangiectasia
|
||||
- Fragile X-associated tremor/ataxia syndrome (FXTAS)
|
||||
- Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)
|
||||
- ## Pathology
|
||||
|
||||
|
||||
- Autosomal dominant ataxia; many SCAs due to PolyQ expansion of coding CAG repeats
|
||||
- Various other gene loci & proteins in remaining SCAs
|
||||
- Commonest mutant genes: *ATXN1* (SCA1), *ATXN2* (SCA2), *ATXN3* (SCA3/MJD),*CACNA1A* (SCA6), *ATN1* (DRPLA)
|
||||
- ## Clinical Issues
|
||||
|
||||
|
||||
- Young to middle-aged patient with slowly progressing cerebellar ataxia & other typical associated symptoms
|
||||
- ## Diagnostic Checklist
|
||||
|
||||
|
||||
- Atrophy of cerebellum ± brainstem
|
||||
- Evaluate axial T2WI for characteristic hyperintense signal in SCA types, especially pons, MCP, periventricular WM
|
||||
|
||||
# TERMINOLOGY
|
||||
|
||||
- ## Abbreviations
|
||||
|
||||
|
||||
- Spinocerebellar ataxia (SCA)
|
||||
- Polyglutamine repeats (PolyQ)
|
||||
- Cytosine-adenine-guanine (CAG)
|
||||
- Machado-Joseph disease (MJD)
|
||||
- Dentatorubropallidoluysian atrophy (DRPLA)
|
||||
- Distance ratio of pontine base:tegmentum (BT-ratio)
|
||||
- ## Synonyms
|
||||
|
||||
|
||||
- MJD = Spinocerebellar ataxia type 3 (SCA3)
|
||||
- ## Definitions
|
||||
|
||||
|
||||
- Slowly progressive cerebellum and cerebellar interconnection neurodegenerative diseases
|
||||
- Autosomal dominant ataxia; many SCAs [SCA1, SCA2, SCA3 (MJD), SCA6, SCA7, SCA12, SCA17] due to PolyQ expansion of coding CAG repeats, similar to Huntington disease
|
||||
- SCA8 shows CTG expansion and complementary CAG repeat
|
||||
- Various other gene loci and proteins in remaining SCAs
|
||||
- SCA type number as per order in which disease identified (by linkage analysis initially and gene discovery lately)
|
||||
- SCA types now 1-40 and beyond; but SCA9, SCA33, and SCA39 not been assigned to specific clinical disorders
|
||||
- SCA1, SCA2, SCA3, SCA6 relatively common types with SCA3 (MJD) being most common among these worldwide
|
||||
- DRPLA, CAG repeat PolyQ expansion disorder that resembles SCA, usually discussed along with SCA
|
||||
|
||||
# IMAGING
|
||||
|
||||
- ## General Features
|
||||
|
||||
|
||||
- ### Best diagnostic clue
|
||||
|
||||
|
||||
- Atrophy of cerebellum ± brainstem
|
||||
- Atrophy difficult to detect in early stage, careful MR analysis needed
|
||||
- ### Location
|
||||
|
||||
|
||||
- Cerebellum always, brainstem often, supratentorial structures variably on volumetric analysis
|
||||
- Early stages of any SCA may show pure cerebellar atrophy and later show brainstem atrophy
|
||||
- ### Size
|
||||
|
||||
|
||||
- Atrophy of involved structures
|
||||
- Cerebellum and **pontine tegmentum (dorsal pons)** atrophy: SCA1, SCA3 (MJD), DRPLA
|
||||
- Cerebellum and **basal pons (ventral pons)** atrophy: SCA2
|
||||
- Cerebellum atrophy purely/predominantly: SCA5, SCA6, SCA11, SCA26, SCA30, SCA31, SCA37
|
||||
- Superior cerebellar peduncle (SCP) atrophy mainly in SCA3 (MJD), SCA6, SCA8, DRPLA
|
||||
- Medulla and upper cervical cord atrophy in SCA3 (MJD); relative lack of cord involvement in SCA6
|
||||
- Severe cerebral atrophy in juvenile-onset DRPLA
|
||||
- Pontine **BT-ratio** useful in diagnostic decision tree
|
||||
- Distance from ventral edge of pons to medial lemniscus (ML): Distance from ML to its dorsal edge
|
||||
- ### Morphology
|
||||
|
||||
|
||||
- Variable abnormal T2/FLAIR hyperintense signal
|
||||
- **Hot cross bun sign** (**HCBS**; cruciform ↑ T2 in pons)
|
||||
- 8.7% overall prevalence in SCA; 25.7% SCA2, 1.3% SCA3 (MJD); extremely rare SCA7, SCA8
|
||||
- Anteroposteriorly oriented **pontine midline** linear T2-**hyperintensity** (**PMH**) in SCA1, SCA3 (MJD), DRPLA
|
||||
- Bilateral **bright middle cerebellar peduncle (MCP) sign** rarely in SCA2, SCA3 (MJD), SCA6, DRPLA
|
||||
- Cerebral white matter (WM), brainstem, and thalamic hyperintensities in adult-onset DRPLA
|
||||
- Cerebral WM usually normal in juvenile-onset DRPLA
|
||||
- Periventricular WM changes may occur very late
|
||||
- ## CT Findings
|
||||
|
||||
|
||||
- Atrophy of involved structures
|
||||
- ## MR Findings
|
||||
|
||||
|
||||
- **SCA types 1 and 3 (SCA1 and SCA3/MJD)**
|
||||
- Pontine tegmentum (dorsal pons) atrophy in early stage
|
||||
- In contrast to multiple system atrophy with predominant cerebellar ataxia (MSA-C)
|
||||
- Important, more common differential diagnosis
|
||||
- MSA-C mainly pontine base (ventral pons) atrophy
|
||||
- Cerebellum and brainstem atrophy prominent later
|
||||
- PMH in later stage on axial T2WI MR; HCBS in 1.3% MJD
|
||||
- In contrast to pontine HCBS in MSA-C commonly
|
||||
- Slightly shrunken neurons of pontine nuclei with preserved cell architecture
|
||||
- Relatively preserves myelinated transverse pontocerebellar fibers
|
||||
- Fiber loss seen only in pontine midline where fibers from right and left pontine nuclei cross
|
||||
- Considered early change of HCBS
|
||||
- Volumetric MR: Caudate/putamen and temporal lobe atrophy in SCA1
|
||||
- Volumetric MR: Temporofrontoparietooccipital, limbic, SCP, basal ganglia, thalamus atrophy in MJD
|
||||
- Medulla/upper cervical cord atrophy, bright MCP in MJD
|
||||
- Progressive linear ↑ T2 just outside ICs (inner segments of globi pallidi) in SCA3 (MJD)
|
||||
- **SCA2**
|
||||
- MR findings **mimicking MSA-C in young** ataxic patient
|
||||
- Prominent cerebellum and brainstem atrophy, more severe than SCA1 and SCA3
|
||||
- Pontine atrophy more prominent in pontine base (ventral pons) than tegmentum (dorsal pons)
|
||||
- Characteristic pontine HCBS in 25%; PMH earlier
|
||||
- Inconsistently, T2 hyperintensities of basal ganglia
|
||||
- Rarely, bilateral MCP focal hyperintensities
|
||||
- Volumetric data shows no cerebral gray matter (GM) or WM atrophy
|
||||
- **SCA5, SCA6, SCA11, SCA26, SCA30, SCA31, SCA37**
|
||||
- Pure/predominantly cerebellar atrophy
|
||||
- **DRPLA**
|
||||
- Cerebellum, brainstem, SCP atrophy
|
||||
- Pontine atrophy is more prominent in pontine tegmentum (dorsal pons) than base (ventral pons)
|
||||
- Rarely, PMH and/or bilateral MCP focal hyperintensities
|
||||
- **Adult-onset DRPLA**: ↑ T2 cerebral WM, brainstem, thalamus
|
||||
- **Juvenile-onset DRPLA**: Cerebral WM usually normal
|
||||
- ↑ T2 periventricular WM in very late stage
|
||||
- Severe cerebral atrophy in juvenile-onset DRPLA
|
||||
- **MRS**
|
||||
- Significantly lower NAA/Cr, Cho/Cr, and NAA/Cho in cerebellar hemispheres/vermis in SCAs, especially SCA2
|
||||
- MSA-C also shows similar findings
|
||||
- ## Imaging Recommendations
|
||||
|
||||
|
||||
- ### Best imaging tool
|
||||
|
||||
|
||||
- MR
|
||||
- ### Protocol advice
|
||||
|
||||
|
||||
- Volumetric 3D T1 MR sequences, such as MPRAGE or SPGR
|
||||
- Axial T2WI and FLAIR to evaluate ↑ T2 like PMH, HCBS
|
||||
|
||||
# DIFFERENTIAL DIAGNOSIS
|
||||
|
||||
- [Multiple System Atrophy - Cerebellar](/document/multiple-system-atrophy/4fb9af00-e0bd-4164-8f61-4011ddc8bf9e)
|
||||
- Most cases sporadic; 6th decade
|
||||
- Atrophy of pons, cerebellum, and inferior olives
|
||||
- Pontine atrophy predominantly at its**base (ventral pons)**
|
||||
- PMH or HCBS in pons on axial T2; bright MCP sometimes
|
||||
- Due to loss of myelinated transverse pontocerebellar fibers
|
||||
- MR mimics SCA2 (consider SCA2 in younger patient)
|
||||
- **SCP spared in MSA-C**; SCP may atrophy in MSA-P, PSP, SCA3/MJD, SCA6, SCA8, DRPLA, Friedrich ataxia, ARSACS
|
||||
- ## Friedrich Ataxia
|
||||
|
||||
|
||||
- Autosomal recessive ataxic disorder
|
||||
- Severe spinal cord atrophy with flat posterior aspect
|
||||
- May show ↑ T2 in spinal cord posterior (fasciculus gracilis and cuneatus) and lateral (pyramidal tracts) columns
|
||||
- Atrophic dorsal medulla, rostral vermis (culmen, declive), inferomedial cerebellar hemisphere, and SCP
|
||||
- Conventionally, cerebellar involvement considered rare, but nowadays volumetric MR shows atrophy
|
||||
- Scoliosis, cardiomyopathy, and stroke due to atrial fibrillation or mural thrombus
|
||||
- ## Ataxia With Oculomotor Apraxia Types 1 and 2
|
||||
|
||||
|
||||
- **Type 1**: Autosomal recessive, mutation in *APTX* gene
|
||||
- MR shows cerebellar atrophy, mild brainstem atrophy
|
||||
- Cortical atrophy in advanced stages
|
||||
- **Type 2**: Autosomal recessive, mutation in *SETX* gene
|
||||
- Peripheral neuropathy and ↑ serum α-fetoprotein
|
||||
- MR shows cerebellar atrophy
|
||||
- ## Ataxia Telangiectasia
|
||||
|
||||
|
||||
- Autosomal recessive ataxic disorder
|
||||
- Normal pons; initially cerebellum may also be normal
|
||||
- MR between 3 and 7 years of age usually shows superior vermian and lateral cerebellar hemispheric atrophy
|
||||
- Later, diffuse cerebellovermian atrophy, including dentate nuclei and cerebellar peduncles
|
||||
- Subtle ↑ FLAIR signal of cerebellar cortex after atrophy
|
||||
- Telangiectasias evident by late childhood and early adult stage using T2*/SWI/postcontrast MR
|
||||
- Supratentorial WM hyperintensities due to spongiosis surrounding telangiectasias
|
||||
- ## Fragile X-Associated Tremor/Ataxia Syndrome
|
||||
|
||||
|
||||
- Late-onset X-linked dominant neurodegeneration
|
||||
- Variable penetrance; males between 50 and 80 years of age
|
||||
- *FMR1* gene mutation affecting CGG trinucleotide repeats
|
||||
- Generalized cerebral, cerebellar, and brainstem atrophy
|
||||
- Periventricular, deep WM and corpus callosum ↑ T2
|
||||
- Characteristic bilateral MCP focal hyperintensities in 60%
|
||||
- ## Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
|
||||
|
||||
|
||||
- Atrophy of anterior cerebellar vermis and SCP 1st
|
||||
- Cerebellar hemisphere, medulla, and cervical cord later
|
||||
- Bulky pons and MCP; subtle ↑ T2 in lateral pons and MCP
|
||||
- Characteristic ↓ T2/FLAIR transverse striations (pontine tigroid hypointensities) in pontine base and tegmentum
|
||||
- DTI shows interruption of thin pyramidal tracts by these hyperplastic pontocerebellar fibers
|
||||
- Rim of T2 hyperintensity around thalami
|
||||
- Straightened spine in radiographs
|
||||
|
||||
# PATHOLOGY
|
||||
|
||||
- ## General Features
|
||||
|
||||
|
||||
- Autosomal dominant ataxia; many SCAs due to PolyQ expansion of coding CAG repeats
|
||||
- Various other gene loci and proteins in remaining SCAs
|
||||
- 60-75% SCA patients only have mutations in known loci
|
||||
- Expansion of CAG repeats produce toxic gain of function
|
||||
- PolyQ SCAs, such as other PolyQ disorders, symptoms manifest above particular CAG repeat threshold
|
||||
- Threshold for symptoms variable for different genes
|
||||
- Threshold in most SCA types > 36, for SCA3 (MJD) > 50
|
||||
- Commonest mutant genes: *ATXN1* (SCA1), *ATXN2*(SCA2), *ATXN3* (SCA3/MJD), *CACNA1A* (SCA6), *ATN1* (DRPLA)
|
||||
- ## Staging, Grading, & Classification
|
||||
|
||||
|
||||
- SCA types currently numbered 1-40 and beyond
|
||||
- Genetic anticipation: Earlier onset and progressive worsening of phenotype in successive generations
|
||||
- ## Gross Pathologic & Surgical Features
|
||||
|
||||
|
||||
- Cerebellar atrophy, variable brainstem atrophy, flattening of facial colliculus in MJD
|
||||
- Neuronal dysfunction and neuronal loss in 10-20 years
|
||||
- Neurodegeneration of pontine reticulotegmental nucleus in SCA1, SCA2, SCA3
|
||||
- Nucleus involved in horizontal smooth pursuit eye movements and accuracy of horizontal saccades
|
||||
|
||||
# CLINICAL ISSUES
|
||||
|
||||
- ## Presentation
|
||||
|
||||
|
||||
- ### Most common signs/symptoms
|
||||
|
||||
|
||||
- Cerebellar ataxia in all SCAs
|
||||
- ### Other signs/symptoms
|
||||
|
||||
|
||||
- SCA1: Pyramidal signs, peripheral neuropathy
|
||||
- SCA2: Slow saccades, myoclonus, areflexia
|
||||
- SCA3/MJD: Slow saccades, persistent stare, extrapyramidal signs, peripheral neuropathy
|
||||
- SCA6: Nystagmus; mild, can be very late onset
|
||||
- Juvenile-onset DRPLA: Myoclonus, seizures, behavioral changes, and intellectual deterioration
|
||||
- Adult-onset DRPLA: Choreoathetosis, delusions, dementia
|
||||
- ## Demographics
|
||||
|
||||
|
||||
- **SCA3 (MJD)****:**Portuguese Azorean, William **Machado** family in New England 1st to be diagnosed with MJD
|
||||
- Azorean Californian **Joseph** family also had MJD
|
||||
- SCAs usually present in middle age
|
||||
- SCA1, 37 years (range: 5-65); SCA2, 35 years (range: 7-66); SCA3, 37 years (range: 5-66); SCA6, 55 years (range: 31-77)
|
||||
- Earlier age of onset and more severe disease with increasing number of CAG repeats on expanded alleles
|
||||
- ## Natural History & Prognosis
|
||||
|
||||
|
||||
- Average SCA disability progression over 1-2 decades
|
||||
- Wheelchair bound by 10-15 years after symptom onset
|
||||
- Higher baseline scores on Scale for the Assessment and Rating of Ataxia (SARA) associated with shorter survival
|
||||
- SCA1 (mean age of death 56 years) more rapid disease progression and shorter survival than SCA2, SCA3, SCA6
|
||||
- ## Treatment
|
||||
|
||||
|
||||
- No effective or curative treatment
|
||||
- Zolpidem: Transient improvement in cerebellar symptoms
|
||||
- Varenicline (partial nicotine agonist): Improvement in some measures of cerebellar dysfunction
|
||||
- Polyglutamine neurotoxicity suppressed by overexpression of heat shock proteins in animal studies
|
||||
- Gene silencing with RNA interference promising in SCA mouse model
|
||||
|
||||
# DIAGNOSTIC CHECKLIST
|
||||
|
||||
- ## Consider
|
||||
|
||||
|
||||
- Young to middle-aged patient with slowly progressing cerebellar ataxia and other typical associated symptoms
|
||||
- ## Image Interpretation Pearls
|
||||
|
||||
|
||||
- Atrophy of cerebellum ± brainstem
|
||||
- Evaluate axial T2WI for characteristic hyperintense signal in SCA types, especially pons, MCP, periventricular WM
|
||||
|
||||
55908b7f-4f89-444c-8107-f53412fe2751
|
||||
Reference in New Issue
Block a user